In a multidisciplinary collaboration, researchers at Vanderbilt University Medical Center and the University of Miami Miller School of Medicine have identified a subtype of triple-negative breast cancer (TNBC) that appears to be able to escape detection by the immune system and evade…
When internal medicine-pediatrics resident Sam Lazaroff, MD, was discharging a patient who had a recurrence of cancer, he quickly realized her loved ones did not understand the severity of her diagnosis and what would be required for her best care after she left the hospital.
Of the nearly 1 million patients diagnosed annually with acute heart failure (AHF) in emergency departments nationwide, more than 80% are hospitalized, even though many could safely be treated at home. The annual cost of treating AHF in U.S. hospitals exceeds $30 billion.
Analogs of signaling molecules called EETs may improve treatment of insulin resistance, a primary risk factor for development of Type 2 diabetes and cardiovascular disease, according to a new paper by researchers at Vanderbilt University Medical Center.
A molecular switch that regulates the cytoskeleton — the cellular equivalent of our skeleton — is required for the maintenance and integrity of the kidney collecting duct, Vanderbilt researchers have found.
An international research team has connected genetic information and data on thousands of proteins circulating in the blood to develop a gene-protein-disease atlas. The new resource, reported Oct.
The National Cancer Institute has funded an ambitious project led by Vanderbilt-Ingram Cancer Center (VICC) to assess the impact of environmental exposures on cancer risk for people living in Southern states.
While drinking tea is reported to have many health benefits, the association of tea consumption and hypertension has been controversial, as large population cohorts are needed to establish findings.
Vanderbilt-Ingram Cancer Center (VICC) is recruiting patients for a clinical trial using photoimmunotherapy for recurrent head and neck cancer.
Vanderbilt University Medical Center is participating in a national study aimed at answering some hard questions about kidney transplantation in the African American community, with the goal of improving patient outcomes.
